Prevalence of inappropriate medication using Beers criteria in Japanese long-term care facilities

BMC Geriatrics

Table 4 Prevalence of inappropriate drug prescription (Dependent on disease or condition)

Disease or condition	Drug	Severity	n/N *	%
Heart failure	Disopyramide, high sodium content drugs	High	4/114	3.5
Seizures or epilepsy	Chlorpromazine, thioridazine	High	2/57	3.5
Blood clotting disorders or receiving anticoagulant therapy	Aspirin, NSAIDs, dipyridamole, ticlopidine	High	4/27	14.8
Stress incontinence**	α-Blockers, anticholinergics, tricyclic antidepressants, long-acting benzodiazepines	High	89/1028	8.7
Arrhythmias	Tricyclic antidepressants	High	1/106	0.9
Insomnia	Decongestants, theophylline, methylphenidate, MAOI, amphetamines	High	4/92	4.3
Parkinson's disease	Metoclopramide, conventional antipsychotics	High	19/88	11.4
Cognitive impairment	Barbiturates, anticholinergics, antispasmodics, muscle relaxants, CNS stimulants	High	52/1273	4.1
Depression	Sympatholytic agents	High	8/119	6.7
Syncope or falls	Short to intermediate-acting benzodiazepine, tricyclic antidepressants	High	23/103	22.3
COPD	Long-acting benzodiazepines, β-blockers	High	1/44	2.3
Chronic constipation	Calcium channel blockers, anticholinergics, tricyclic antidepressants	Low	165/548	30.1
Use of any of above for each disease or condition			300/1669	18.0

* N: Number of patients with the disease or condition. n: Number of patients treated with any of drug(s) that are inappropriate for that disease or condition.
** We could not identify the patients with 'stress incontinence' because the MDS data were limited to 'incontinence' in general.

ISSN: 1471-2318